AHAG yields 2000000.00% · MRK yields 2.76%● Live data
📍 AHAG pulled ahead of the other in Year 1
Combined, AHAG + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AHAG + MRK for your $10,000?
Alpha Technologies Group, Inc., through its subsidiaries, manufactures, fabricates, and sells thermal management and non-thermal fabricated products, and aluminum extrusions in the United States. It offers natural convection products, which include thermal extrusions, board level and BGA heatsinks, LED heat sinks, folded fins, bonded and stacked fins, and heat frames; forced convection products, such as skived and zipper fins, and fans; fluid phase change products, including heat pipes; and liquid cooling products, such as liquid cold plates, heat exchangers, and coolant distribution units. The company also provides accessories, such as wedgelocks, front panels, enclosures, precision clamps, thermal interface material, and data center cooling accessories; and universal joints, which include alves blue blocks, solid blocks, hex blocks, double universal joints, needle bearings, and universal joint accessories. In addition, it offers engineering, such as applications engineering and design services; manufacturing, which include extrusion, fabrication, machining services, and quick turn prototyping; supply chain services; and data center cooling services. It serves aerospace/defense, architecture, power conversion, information tech, renewable energy, telecommunications, led lighting, factory automation, consumer, medical, and transportation industries; and construction, sporting goods, and other leisure activity markets. Alpha Technologies Group, Inc. was formerly known as Synercom Technology, Inc. and changed its name to Alpha Technologies Group, Inc. in 1995. The company was founded in 1969 and is based in Los Angeles, California.
Full AHAG Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.